Havana Research Institute LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Atrial fibrillation1 trial
• Graves' disease and hyperthyroidism1 trial

Phase

• Phase 32 trials
• Phase 2/31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• ACADIA Pharmaceuticals Inc.1 trial
• argenx1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

  NCT07570316· Phase 3· argenx· Source

  Contact: John De Beixedon, MD

• Recruiting

  ACP-204 in Adults With Alzheimer's Disease Psychosis

  NCT06159673· Phase 2/3· ACADIA Pharmaceuticals Inc.· Source

  Contact: Christine Murphy

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Graves' disease and hyperthyroidism1 recruiting